Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Brend

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
BMC Cancer|April 14, 2022
HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiformeEinthavy Arunachalam, William Rogers, Guy R Simpson, et al.
Cancers|December 10, 2021
GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic ModelsAnke Brüning-Richardson, Gary C Shaw, Daniel Tams, et al.
BMJ Open|November 29, 2023
Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocolMark A Hull, Pei Loo Ow, Sharon Ruddock, et al.
Cancers|August 12, 2022
Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. <i>Cancers</i> 2021, <i>13</i>, 5939Anke Brüning-Richardson, Gary C Shaw, Daniel Tams, et al.
Oncogene|February 19, 2020
EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastomaNina Struve, Zev A Binder, Lucy F Stead, et al.
The Journal of Pathology|December 20, 2018
shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growthHarry R Haynes, Helen L Scott, Clare L Killick-Cole, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
BMC Cancer|April 14, 2022
HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiformeEinthavy Arunachalam, William Rogers, Guy R Simpson, et al.
Cancers|December 10, 2021
GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic ModelsAnke Brüning-Richardson, Gary C Shaw, Daniel Tams, et al.
BMJ Open|November 29, 2023
Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocolMark A Hull, Pei Loo Ow, Sharon Ruddock, et al.
Cancers|August 12, 2022
Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. <i>Cancers</i> 2021, <i>13</i>, 5939Anke Brüning-Richardson, Gary C Shaw, Daniel Tams, et al.
Oncogene|February 19, 2020
EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastomaNina Struve, Zev A Binder, Lucy F Stead, et al.
The Journal of Pathology|December 20, 2018
shRNA-mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growthHarry R Haynes, Helen L Scott, Clare L Killick-Cole, et al.
Pageof 2